Literature DB >> 18978893

High-speed, high-resolution Fourier-domain optical coherence tomography system for retinal imaging in the 1060 nm wavelength region.

Prabakar Puvanathasan1, Peter Forbes, Zhao Ren, Doug Malchow, Shelley Boyd, Kostadinka Bizheva.   

Abstract

A high-speed (47,000 A-scans/s), ultrahigh axial resolution Fourier domain optical coherence tomography (OCT) system for retinal imaging at approximately 1060 nm, based on a 1024 pixel linear array, 47 kHz readout rate InGaAs camera is presented. When interfaced with a custom superluminescent diode (lambda(c) = 1020 nm, Deltalambda = 108 nm, Pout = 9 mW), the system provides 3.3 microm axial OCT resolution at the surface of biological tissue, approximately 4.5 microm in vivo in rat retina, approximately 5.7 microm in vivo in human retina, and 110 dB sensitivity for 870 microW incident power and 21 mus integration time. Retinal tomograms acquired in vivo from a human volunteer and a rat animal model show clear visualization of all intraretinal layer and increased penetration into the choroid.

Entities:  

Mesh:

Year:  2008        PMID: 18978893     DOI: 10.1364/ol.33.002479

Source DB:  PubMed          Journal:  Opt Lett        ISSN: 0146-9592            Impact factor:   3.776


  11 in total

1.  High resolution in vivo imaging of the lamina cribrosa.

Authors:  Sung C Park; Robert Ritch
Journal:  Saudi J Ophthalmol       Date:  2011-05-08

2.  Multi-penalty conditional random field approach to super-resolved reconstruction of optical coherence tomography images.

Authors:  Ameneh Boroomand; Alexander Wong; Edward Li; Daniel S Cho; Betty Ni; Kostandinka Bizheva
Journal:  Biomed Opt Express       Date:  2013-09-06       Impact factor: 3.732

3.  High-speed 1310 nm-band spectral domain optical coherence tomography at 184,000 lines per second.

Authors:  Lin An; Guangying Guan; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2011-06       Impact factor: 3.170

4.  Changes in choroidal thickness in healthy pediatric individuals: a longitudinal study.

Authors:  Eiko Ohsugi; Yoshinori Mitamura; Kayo Shinomiya; Masanori Niki; Hiroki Sano; Toshihiko Nagasawa; Yukiko Shimizu; Daisuke Nagasato; Hitoshi Tabuchi
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

5.  Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT.

Authors:  Li Guo; Eduardo M Normando; Shereen Nizari; David Lara; M Francesca Cordeiro
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-04       Impact factor: 4.799

Review 6.  Three dimensional optical coherence tomography imaging: advantages and advances.

Authors:  Michelle L Gabriele; Gadi Wollstein; Hiroshi Ishikawa; Juan Xu; Jongsick Kim; Larry Kagemann; Lindsey S Folio; Joel S Schuman
Journal:  Prog Retin Eye Res       Date:  2010-06-11       Impact factor: 21.198

7.  Spectral-domain optical coherence tomography enhanced depth imaging of the normal and glaucomatous nonhuman primate optic nerve head.

Authors:  Hongli Yang; Jingjing Qi; Christy Hardin; Stuart K Gardiner; Nicholas G Strouthidis; Brad Fortune; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

8.  Automated measurement of choroidal thickness in the human eye by polarization sensitive optical coherence tomography.

Authors:  Teresa Torzicky; Michael Pircher; Stefan Zotter; Marco Bonesi; Erich Götzinger; Christoph K Hitzenberger
Journal:  Opt Express       Date:  2012-03-26       Impact factor: 3.894

9.  In vivo volumetric imaging of chicken retina with ultrahigh-resolution spectral domain optical coherence tomography.

Authors:  Alireza Akhlagh Moayed; Sepideh Hariri; Eun Sun Song; Vivian Choh; Kostadinka Bizheva
Journal:  Biomed Opt Express       Date:  2011-04-19       Impact factor: 3.732

10.  Tensor total variation approach to optical coherence tomography reconstruction for improved visualization of retinal microvasculature.

Authors:  Alexander Wong; Sepideh Hariri; Eun Sun Song; Kostadinka Bizheva
Journal:  Biomed Opt Express       Date:  2011-12-19       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.